Mission Statement, Vision, & Core Values (2026) of TECON BIOLOGY Co.LTD.

Founded in 1993, TECON BIOLOGY Co. LTD (002100.SZ) stands as a diversified Chinese agribusiness-spanning animal healthcare, feed, pig breeding, food processing, protein oil and financial services-with a workforce of about 5,004 and a market capitalization near 9.47 billion CNY (late 2025); despite a FY2024 revenue of 17.18 billion CNY (a 9.72% decline year-over-year), the company channels over 15% of revenue into R&D, supported historically by a 2022 revenue base near $150 million and an R&D investment of roughly $22.5 million, and serves a growing farmer network (10,000+ users by 2023 with ambitions to exceed 11,000) by delivering biotechnology that has reportedly raised yields ~20% while targeting a 30% reduction in agricultural carbon footprint by 2025-read on to explore how TECON's mission, vision and core values drive these measurable commitments and industry-facing strategies.

TECON BIOLOGY Co.LTD (002100.SZ) - Intro

• Established: 1993
• Divisions: Feed, Pharmaceutical, Food Farming, Protein Oil, Agricultural Products
• Employees: 5,004 (approx.)
• Market capitalization (late 2025): 9.47 billion CNY
• Fiscal year end: December 31, 2024

• To enhance animal health and food security through science-driven feed and pharmaceutical solutions that elevate farm productivity and product quality.
• To deliver integrated value across the agricultural chain - from farm inputs and breeding to processing and downstream consumer products.

• To be a leading, technology-enabled agribusiness in China and a trusted partner for sustainable animal protein supply.
• To scale innovation such that scientific advances in veterinary medicine and feed translate into measurable gains for farmers, consumers, and investors.

• Science-led innovation - prioritizing R&D investment to develop safer, more effective animal health and nutrition products.
• Integration & efficiency - optimizing upstream feed and breeding with downstream processing to improve margin capture.
• Food safety & sustainability - committing to responsible production and traceability across protein and agricultural products.
• Customer-centric service - supporting farmers and supply-chain partners with technical, financial, and operational tools.
• Accountability & governance - transparent reporting and disciplined capital allocation focused on long-term value.

• Increase R&D intensity: maintain >15% of annual revenue toward R&D (FY 2024 base ≈ 2.58 billion CNY).
• Improve operational margins through vertical integration across Feed → Farming → Processing.
• Scale high-margin pharmaceutical and specialty nutrition products to offset volatility in commodity-linked segments.
• Expand market share in targeted provincial breeding hubs and downstream processing facilities to drive revenue recovery from 2024 declines.

• R&D pipeline and product approvals - primary driver of pharmaceutical and specialty feed growth.
• Integrated supply chain efficiencies - feed formulation, breeding performance, and processing yields.
• Commodity price management and hedging in Protein Oil and Agricultural Products divisions.
• Selective M&A or strategic partnerships to secure feedstock, technology, and market access.

TECON BIOLOGY Co.LTD (002100.SZ) - Overview

• TECON BIOLOGY is committed to innovating and delivering advanced biotechnological solutions that enhance agricultural productivity and sustainability.
• The company aims to meet growing global food demand while minimizing environmental impacts through its products and practices.
• TECON BIOLOGY invests aggressively in innovation, targeting over 15% of annual revenue for research and development to accelerate next‑generation agricultural technologies.

• To be a global leader in sustainable agricultural biotechnology, enabling resilient food systems through scalable, science‑driven solutions.
• To empower farmers worldwide with affordable, technology‑based products that increase yields and reduce ecological footprint.

• Science‑led innovation - prioritizing reproducible research and measurable agronomic benefits.
• Farmer empowerment - developing user‑centric technologies that translate to on‑farm value.
• Environmental stewardship - designing products and processes that lower inputs and protect ecosystems.
• Transparency and integrity - clear reporting of performance, safety, and financial commitments.

• With an R&D allocation of roughly $22.5M in 2022, TECON BIOLOGY channels significant resources into product pipelines, field trials, and regulatory support to scale adoption.
• Direct adoption by 10,000+ farmers indicates meaningful market penetration for biological products that claim ~20% yield uplift, translating into substantial food production gains at scale.
• Investment focus on sustainability aims to reduce chemical inputs and associated environmental externalities while improving farm profitability.

TECON BIOLOGY Co.LTD (002100.SZ) - Mission Statement

• Develop and commercialize bio-based inputs that increase yields while minimizing chemical dependency.
• Drive accessible technology transfer to small- and mid-scale farms to enhance resilience and profitability.
• Collaborate with research institutions and industry partners to accelerate scalable solutions for soil health, pest management, and nutrient efficiency.
• Measure and minimize the environmental footprint of agricultural practices through data-driven interventions.

• Scale market reach to serve over 11,000 farmers by 2023 (company target).
• Reduce the carbon footprint of agricultural practices by 30% by 2025 through product adoption, optimized application regimes, and integrated carbon-reduction programs.
• Position biotechnology as a core pillar of sustainable food systems and contribute to global food security.
• Expand international partnerships and distribution channels to accelerate global impact.

• Environmental stewardship: prioritize products and practices that reduce emissions, improve soil carbon sequestration, and lower reliance on synthetic agrochemicals.
• Farmer outcomes: measure adoption by hectares treated, yield uplift percentage, and input-cost savings per farm.
• Transparency: publish annual impact metrics-e.g., farmers served, estimated CO2e avoided, and hectares under treatment-to track progress against targets.

• Adoption metrics: number of farmers, hectares treated, repeat-purchase rate.
• Environmental KPIs: estimated CO2e reduction, reductions in synthetic nitrogen use, soil organic matter improvements.
• Commercial KPIs: product revenue growth, market penetration in targeted regions, R&D pipeline milestones.

TECON BIOLOGY Co.LTD (002100.SZ) - Vision Statement

• Be a global leader in agricultural biostimulants and bio-pesticides by leveraging proprietary strains, fermentation platforms, and formulation technologies.
• Drive net-positive environmental impact by reducing agrochemical reliance and enhancing biodiversity in cropping systems.
• Create durable farmer value through cost-effective inputs, agronomic support, and digital decision tools.
• Foster open collaboration with research institutions, supply-chain partners, and policy stakeholders to scale sustainable practices.

• Innovation: Sustained R&D investment - target of allocating 8-12% of annual revenue to R&D, with multi-year pipelines for new microbial strains and formulations.
• Sustainability: Product portfolio aimed at replacing at least 20-30% of conventional synthetic inputs in target crops by 2030 in deployed regions.
• Customer-centricity: On-farm trials and extension programs - routinely supporting 1,000+ pilot farms per crop cycle in major markets to validate efficacy and collect agronomic data.
• Integrity: Transparent reporting standards, third-party field validation, and compliance with GLP/GMP where applicable.
• Collaboration: Formal partnerships with universities and agricultural institutes; co-authored field studies and joint commercialization agreements.
• Continuous improvement: Annual product performance reviews, iterative formulation upgrades, and customer feedback loops integrated into product roadmaps.

• Innovation: Deployment of a proprietary Bacillus consortium that, in multi-location trials, delivered yield uplifts of 6-12% while reducing nitrogen fertilizer use by 10-20% (trial averages depend on crop and region).
• Sustainability: Lifecycle assessments used to quantify reductions in greenhouse gas intensity per ton of crop produced when products replace synthetic alternatives.
• Customer-centricity: Agronomy hotline and digital advisory tools delivering tailored application recommendations based on soil tests and local climate data.
• Integrity & Collaboration: Open-access summaries of trial results and joint publications with university partners to validate claims.
• Continuous improvement: Annual reformulation cycles that improve shelf-life and field efficacy based on laboratory stability data and farmer feedback.